Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Nurix Therapeutics Inc (NASDAQ: NRIX) was $22.28 for the day, up 0.54% from the previous closing price of $22.16. In other words, the price has increased by $0.54 from its previous closing price. On the day, 0.45 million shares were traded. NRIX stock price reached its highest trading level at $22.69 during the session, while it also had its lowest trading level at $21.75.
Ratios:
Our analysis of NRIX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.57 and its Current Ratio is at 5.57. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on July 31, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On March 09, 2023, Barclays started tracking the stock assigning a Overweight rating and target price of $20.Barclays initiated its Overweight rating on March 09, 2023, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 01 ’24 when van Houte Hans sold 3,477 shares for $21.45 per share. The transaction valued at 74,576 led to the insider holds 51,002 shares of the business.
Ring Christine sold 5,760 shares of NRIX for $123,459 on Aug 01 ’24. The Chief Legal Officer now owns 24,592 shares after completing the transaction at $21.43 per share. On Aug 01 ’24, another insider, JOHANNES VAN HOUTE, who serves as the Officer of the company, bought 3,477 shares for $21.88 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1435097216 and an Enterprise Value of 1020776448. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.03 while its Price-to-Book (P/B) ratio in mrq is 3.87. Its current Enterprise Value per Revenue stands at 16.384 whereas that against EBITDA is -5.926.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $24.38, while it has fallen to a 52-week low of $4.22. The 50-Day Moving Average of the stock is 10.45%, while the 200-Day Moving Average is calculated to be 68.02%.
Shares Statistics:
NRIX traded an average of 1.00M shares per day over the past three months and 573430 shares per day over the past ten days. A total of 64.41M shares are outstanding, with a floating share count of 63.26M. Insiders hold about 1.68% of the company’s shares, while institutions hold 100.92% stake in the company. Shares short for NRIX as of 1722384000 were 9321186 with a Short Ratio of 9.29, compared to 1719532800 on 8073745. Therefore, it implies a Short% of Shares Outstanding of 9321186 and a Short% of Float of 15.640001.
